Cancer in People with HIV/Kaposi Sarcoma Panel - Disclosures
Panel Member
|
Borislav Alexiev MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kevin Ard MD, MPH |
Grant/Research Support
|
| Binx Health |
Royalty Income
|
| McGraw-Hill | UpToDate |
Date Completed
|
07/31/2024 |
Panel Member
|
Robert Baiocchi MD, PhD |
Equity Interest/Stock Options
|
| Viracta Therapeutics |
Date Completed
|
07/26/2024 |
Panel Member
|
Nicole Blankenhorn |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Thomas Campbell MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evie Carchman MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Stuart Cohen MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mark Dickson MD |
Grant/Research Support
|
| AADi | Eli Lilly and Company | Sumitomo |
Date Completed
|
10/07/2024 |
Panel Member
|
Gregory Eschenauer PharmD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Deborah Freedman-Cass PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Gaurav Goyal MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Kristina Gregory MSN, RN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Juneko Grilley-Olson MD |
Grant/Research Support
|
| Boehringer Ingelheim GmbH | Inhibrx | Polaris | PTC therapeutics |
Date Completed
|
08/07/2024 |
Panel Member
|
Ajay Gupta MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Henry MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Brianna Herron PharmD, BCOP, BCPS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Hesler |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Amy Jones MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ann Klopp MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Mark Korpics MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ann LaCasce MD, MMSc |
Product/Speakers Bureau
|
| Research to Practice |
Date Completed
|
03/14/2025 |
Panel Member
|
Teresa Lee MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Chi Lin MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Toby Maurer MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Manoj Menon MD, MPH |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Morgan MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nitya Nathwani MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
David Palm MS |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Henry Park MD, MPH |
Grant/Research Support
|
| Merck & Co., Inc. |
Date Completed
|
04/20/2025 |
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Lee Ratner MD, PhD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Erin Reid MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Stacey Rizza MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Julian Sanchez MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Nicholas Sansone MA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Ryan Schonfeld BA |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
John Schorge MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Gita Suneja MD, MSHP |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
John Timmerman MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Amanda Visnick BSN, RN, OCN |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
Panel Member
|
Samantha Vogt MD, MPH |
Grant/Research Support
|
| Bristol Myers Squibb |
Date Completed
|
03/26/2025 |
Panel Member
|
Chia-Ching Wang MD |
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |